Date:
May 8, 2026
Content:
The U.S. Food and Drug Administration (FDA) has released a Form 483 regarding Wells Pharmacy Inc., an outsourcing facility located in Dyersburg, Tennessee, following an inspection concluded in April 2026.
The FDA issued the Form 483 on April 9, 2026, to the management of Wells Pharmacy Inc. (FEI Number 3011761321). This document is typically issued at the conclusion of an inspection when investigators observe conditions that may constitute violations of the Food, Drug, and Cosmetic Act. The record has been officially posted to the OII FOIA Electronic Reading Room for public access.
As a registered outsourcing facility, Wells Pharmacy Inc. is subject to federal oversight and must adhere to specific quality standards for compounded medications. The publication of this Form 483 highlights the FDA’s ongoing efforts to ensure compliance within the pharmaceutical compounding industry and to provide transparency regarding facility inspections.
Source: FDA Electronic Reading Room
Link:
http://www.fda.gov/about-fda/fda-commissioner/wells-pharmacy-inc-dyersburg-tn-483-issued-4092026
Keywords:
FDA, Wells Pharmacy Inc, Form 483, Outsourcing Facility, Tennessee, Pharmaceutical Inspection